MyFinsight
Home
Blog
About
Contact
Download
Download image
Changes in fair value of
warrant liabilities
-$62,754,186
Other income
$3,133,784
Interest income
$1,432,032
Total other income
$62,227,046
Warrant issuance
expense
$4,852,292
Interest expense
$240,664
Net income (loss)
$13,273,683
Unrealized gain, change in
fair value of...
$185,464
Foreign currency
translation gain (loss)
$136,456
Loss from operations
-$48,953,363
Total comprehensive
income (loss)
$13,595,603
Total operating
expenses
$48,953,363
Research and development
$34,352,332
General and
administrative
$14,601,031
Back
Back
Income Statement
source: myfinsight.com
SAB Biotherapeutics, Inc. (SABSW)
SAB Biotherapeutics, Inc. (SABSW)